AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32

Authors: D'Anna, R Le Buanec, H Bizzini, B Burny, A Giannouli, C Zagury, JF Gallo, RC Zagury, D D'Alessio, P
Citation: R. D'Anna et al., Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesionmolecules in cervical endothelial cells but not in human umbilical vein endothelial cells, J HUMAN VIR, 4(2), 2001, pp. 85-95

Authors: Reid, W Sadowska, M Denaro, F Rao, S Foulke, J Hayes, N Jones, O Doodnauth, D Davis, H Sill, A O'Driscoll, P Huso, D Fouts, T Lewis, G Hill, M Kamin-Lewis, R Wei, C Ray, P Gallo, RC Reitz, M Bryant, J
Citation: W. Reid et al., An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction, P NAS US, 98(16), 2001, pp. 9271-9276

Authors: Kamin-Lewis, R Abdelwahab, SF Trang, C Baker, A DeVico, AL Gallo, RC Lewis, GK
Citation: R. Kamin-lewis et al., Perforin-low memory CD8(+) cells are the predominant T cells in normal humans that synthesize the beta-chemokine macrophage inflammatory protein-1 beta, P NAS US, 98(16), 2001, pp. 9283-9288

Authors: Zagury, D Burny, A Gallo, RC
Citation: D. Zagury et al., Toward a new generation of vaccines: The anti-cytokine therapeutic vaccines, P NAS US, 98(14), 2001, pp. 8024-8029

Authors: Gallo, RC
Citation: Rc. Gallo, The Dr. Maurice Hilleman Symposium, August 30, 1999, in honor of his 80(th) birthday - Introduction, J HUMAN VIR, 3(2), 2000, pp. 59-59

Authors: Gallo, RC
Citation: Rc. Gallo, The path to the discoveries of human retroviruses, J HUMAN VIR, 3(1), 2000, pp. 1-5

Authors: Gallo, RC
Citation: Rc. Gallo, New concepts for future control of HIV derived from studies of pathogenesis, INT J ANT A, 16(4), 2000, pp. 421-423

Authors: Garzino-Demo, A DeVico, AL Conant, KE Gallo, RC
Citation: A. Garzino-demo et al., The role of chemokines in human immunodeficiency virus infection, IMMUNOL REV, 177, 2000, pp. 79-87

Authors: Pauza, CD Trivedi, P Wallace, M Ruckwardt, TJ Le Buanec, H Lu, W Bizzini, B Burny, A Zagury, D Gallo, RC
Citation: Cd. Pauza et al., Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques, P NAS US, 97(7), 2000, pp. 3515-3519

Authors: Secchiero, P Zella, D Curreli, S Mirandola, P Capitani, S Gallo, RC Zauli, G
Citation: P. Secchiero et al., Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4(+) T cell hyperactivation and HIV type 1 replication, P NAS US, 97(26), 2000, pp. 14620-14625

Authors: Cocchi, F DeVico, AL Yarchoan, R Redfield, R Cleghorn, F Blattner, WA Garzino-Demo, A Colombino-Hatch, S Margolis, D Gallo, RC
Citation: F. Cocchi et al., Higher macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta levelsfrom CD8(+) T cells are associated with asymptomatic HIV-1 infection, P NAS US, 97(25), 2000, pp. 13812-13817

Authors: Secchiero, P Zella, D Curreli, S Mirandola, P Capitani, S Gallo, RC Zauli, G
Citation: P. Secchiero et al., Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4(+) T cells, J IMMUNOL, 164(8), 2000, pp. 4018-4024

Authors: Zella, D Romerio, F Curreli, S Secchiero, P Cicala, C Zagury, D Gallo, RC
Citation: D. Zella et al., IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primaryCD4(+) T cells, J IMMUNOL, 164(5), 2000, pp. 2296-2302

Authors: Cleghorn, FR Gallo, RC
Citation: Fr. Cleghorn et Rc. Gallo, HIV, HTLV and cancer, PROG ANTI C, 4, 2000, pp. 63-83

Authors: Samaniego, F Bryant, JL Liu, N Karp, JE Sabichi, AL Thierry, A Lunardi-Iskandar, Y Gallo, RC
Citation: F. Samaniego et al., Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin, J NAT CANC, 91(2), 1999, pp. 135-143

Authors: Reitz, MS Nerurkar, LS Gallo, RC
Citation: Ms. Reitz et al., Perspective on Kaposi's sarcoma: Facts, concepts, and conjectures, J NAT CANC, 91(17), 1999, pp. 1453-1458

Authors: Gringeri, A Santagostino, E Muca-Perja, M Le Buanec, H Bizzini, B Lachgar, A Zagury, JF Rappaport, J Burny, A Gallo, RC Zagury, D
Citation: A. Gringeri et al., Tat toxoid as a component of a preventive vaccine in seronegative subjects, J ACQ IMM D, 20(4), 1999, pp. 371-375

Authors: Weichold, FF Bryant, JL Pati, S Barabitskaya, O Gallo, RC Reitz, MS
Citation: Ff. Weichold et al., HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells, J HUMAN VIR, 2(5), 1999, pp. 261-269

Authors: Gallo, RC
Citation: Rc. Gallo, A personal perspective on HIV-AIDS research, J HUMAN VIR, 2(1), 1999, pp. 8-18

Authors: Gallo, RC
Citation: Rc. Gallo, Thematic review series XI: Viruses in the origin of human cancer introduction and overview - Introduction and overview, P ASS AM PH, 111(6), 1999, pp. 560-562

Authors: Le Buanec, H D'Anna, R Lachgar, A Zagury, JF Bernard, J Ittele, D d'Alessio, P Hallez, S Giannouli, C Burny, A Bizzini, B Gallo, RC Zagury, D
Citation: H. Le Buanec et al., HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes, BIOMED PHAR, 53(9), 1999, pp. 424-431

Authors: Gallo, RC Garzino-Demo, A DeVico, AL
Citation: Rc. Gallo et al., HIV infection and pathogenesis: What about chemokines?, J CLIN IMM, 19(5), 1999, pp. 293-299

Authors: Gallo, RC
Citation: Rc. Gallo, The enigmas of Kaposi's sarcoma (vol 282, pg 1837, 1998), SCIENCE, 283(5405), 1999, pp. 1118-1118

Authors: Garzino-Demo, A Moss, RB Margolick, JB Cleghorn, F Sill, A Blattner, WA Cocchi, F Carlo, DJ DeVico, AL Gallo, RC
Citation: A. Garzino-demo et al., Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status, P NAS US, 96(21), 1999, pp. 11986-11991

Authors: Gallo, RC
Citation: Rc. Gallo, Tat as one key to HIV-induced immune pathogenesis and Pat toroid as an important component of a vaccine, P NAS US, 96(15), 1999, pp. 8324-8326
Risultati: 1-25 | 26-32